 |
| 17-May-13 01:04PM | HARVARD BIOSCIENCE INC Financials EDGAR Online Financials |
| 11:04AM | Finding Investment Opportunities in Quality Growth Health Care Companies That the Rest of the Market is Overlooking Wall Street Transcript |
| 15-May-13 11:04PM | HARVARD BIOSCIENCE INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 11:26AM | Harvard Bioscience CEO Graziano will retire AP |
| 07:30AM | InPlay: Harvard Bioscience announces retirement of CEO and appointment of interim CEO Briefing.com |
| 07:30AM | Harvard Bioscience Announces Retirement of CEO and Appointment of Interim CEO GlobeNewswire |
| 10-May-13 05:49AM | HARVARD BIOSCIENCE INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 07-May-13 01:55PM | Short On Oculus: Wound Care Company Has Left Dirty Scars at Seeking Alpha |
| 08:08AM | HARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online |
| 02-May-13 07:33AM | InPlay: Harvard Biosci misses by $0.03 Briefing.com |
| 07:07AM | Q1 2013 Harvard Bioscience, Inc. Earnings Release - Before Market Open CCBN |
| 07:00AM | HBIO Reports First Quarter 2013 Results GlobeNewswire |
| 01-May-13 06:53PM | On The Fly: After Hours Movers at theflyonthewall.com -5.27% |
| 05:38PM | InPlay: Harvard Biosci affirms plan to spin-off Harvard Apparatus Regenerative Technology, Inc. and announces its intended path forward Briefing.com |
| 05:37PM | HBIO Affirms Plan to Spin-Off Harvard Apparatus Regenerative Technology, Inc. and Announces Its Intended Path Forward GlobeNewswire |
| 30-Apr-13 07:11PM | Webcast Now Available of Press Conference Discussing Landmark Surgery Involving Harvard Bioscience's Synthetic Trachea Scaffold and "InBreath" Bioreactor GlobeNewswire +7.79% |
| 11:00AM | Photo Release -- Harvard Apparatus Regenerative Technology's "InBreath" Scaffold and Bioreactor Used in First U.S. Transplant of a Regenerated Trachea GlobeNewswire |
| 07:00AM | Harvard Bioscience to Participate in Press Conference Today to Discuss Landmark Surgery GlobeNewswire |
| 26-Apr-13 02:00PM | Harvard Bioscience, Inc. Schedules First Quarter 2013 Conference Call for May 2, 2013 GlobeNewswire |
| 12-Apr-13 05:00AM | [video] The Five Dumbest Things on Wall Street: April 12 at TheStreet |
| 11-Apr-13 12:48PM | 4 Healthcare Stock Stories for Thursday Investment Wellness at Wall St. Cheat Sheet |
| 10-Apr-13 01:35PM | Harvard Bioscience down after delaying unit's IPO AP -13.57% |
| 12:36PM | Harvard Bioscience Getting Very Oversold at Forbes |
| 09-Apr-13 06:41PM | Harvard Bioscience delays regenerative tech IPO AP |
| 05:22PM | InPlay: Harvard Biosci announces postponement of the IPO for Harvard Apparatus Regenerative Technology, Inc. Briefing.com |
| 05:21PM | HBIO Announces Postponement of the IPO for Harvard Apparatus Regenerative Technology, Inc. GlobeNewswire |
| 03-Apr-13 09:32AM | HARVARD BIOSCIENCE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial EDGAR Online |
| 02-Apr-13 07:04AM | InPlay: Harvard Biosci files request for acceleration of effectiveness for Harvard Apparatus Regenerative Technology IPO registration statement Briefing.com |
| 07:00AM | HBIO Announces Filing of Request for Acceleration of Effectiveness for Harvard Apparatus Regenerative Technology, Inc.'s IPO Registration Statement GlobeNewswire |
| 29-Mar-13 01:21PM | Harvard Bioscience prepares HART spinoff; HART readies for IPO at bizjournals.com |
| 26-Mar-13 09:09AM | Chevron Strikes Oil in Mexico and 4 Stocks At 52-Week Highs at Wall St. Cheat Sheet |
| 25-Mar-13 07:21AM | Harvard Bioscience to IPO Harvard Apparatus Regenerative Technology unit theflyonthewall.com |
| 07:04AM | InPlay: Harvard Biosci announces receipt of private letter ruling and affirms plan to spin-off harvard apparatus regenerative technology following its IPO; HART has set a price range of $10.00 - $12.00 per share of common stock Briefing.com |
| 07:00AM | Harvard Bioscience, Inc. Announces Receipt of Private Letter Ruling and Affirms Plan to Spin-Off Harvard Apparatus Regenerative Technology, Inc. Following Its Initial Public Offering GlobeNewswire |
| 21-Mar-13 01:04PM | HARVARD BIOSCIENCE INC Financials EDGAR Online Financials |
| 18-Mar-13 08:23AM | HARVARD BIOSCIENCE INC Files SEC form 10-K, Annual Report EDGAR Online |
| 14-Mar-13 05:02PM | HARVARD BIOSCIENCE INC Files SEC form 8-K, Amendment or Waiver to Code of Ethics, Financial Statements and Exhibits EDGAR Online |
| 04-Mar-13 04:48PM | HARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online |
| 02-Mar-13 09:11PM | New Star Analyst Rankings for Harvard Bioscience, Inc. StarMine |
| 01-Mar-13 07:30PM | New Star Analyst Rankings for Harvard Bioscience, Inc. StarMine |
| 09:36AM | Jarden Increases Buybacks & 3 Stocks Hitting 52-Week Highs at Wall St. Cheat Sheet |
| 28-Feb-13 01:40PM | Harvard Bioscience Management Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 07:07AM | Q4 2012 Harvard Bioscience, Inc. Earnings Release - Before Market Open CCBN |
| 07:00AM | HBIO Reports Fourth Quarter 2012 Results GlobeNewswire |
| 25-Feb-13 03:52PM | Harvard Bioscience, Inc. Schedules Fourth Quarter 2012 Conference Call for February 28, 2013 GlobeNewswire |
| 23-Jan-13 03:38AM | Why Harvard Bioscience Is Poised to Pop at Motley Fool |
| 18-Jan-13 03:12PM | I'm Putting Real Money on Harvard Bioscience at Motley Fool |
| 10-Jan-13 04:00AM | Harvard Bioscience Inc. Stock Upgraded (HBIO) at TheStreet |
| 12-Dec-12 04:57PM | Harvard Bioscience Announces Filing of IPO Registration Statement for Harvard Apparatus Regenerative Technology at Forbes +12.93% |
| 12:05PM | Harvard Bioscience shares rise on unit's IPO plans AP |
| 10:07AM | Harvard Bioscience stock rises post subsidiary IPO news at bizjournals.com |
| 09:41AM | InPlay from Briefing.com Briefing.com |
| 09:09AM | InPlay from Briefing.com Briefing.com |
| 08:31AM | InPlay from Briefing.com Briefing.com |
| 06:17AM | InPlay from Briefing.com Briefing.com |
| 06:03AM | InPlay from Briefing.com Briefing.com |
| 04:33AM | InPlay from Briefing.com Briefing.com |
| 03:24AM | InPlay from Briefing.com Briefing.com |
| 02:04AM | InPlay from Briefing.com Briefing.com |
| 01:42AM | InPlay from Briefing.com Briefing.com |
| 01:08AM | InPlay from Briefing.com Briefing.com |
| 11-Dec-12 06:36PM | InPlay from Briefing.com Briefing.com |
| 05:55PM | InPlay from Briefing.com Briefing.com |
| 05:22PM | InPlay from Briefing.com Briefing.com |
| 04:53PM | InPlay from Briefing.com Briefing.com |
| 04:44PM | HARVARD BIOSCIENCE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 04:42PM | InPlay: Harvard Biosci announces filing of IPO Registration Statement for Harvard Apparatus Regenerative Technology, Inc. Briefing.com |
| 04:40PM | Harvard Bioscience, Inc. Announces Filing of IPO Registration Statement for Harvard Apparatus Regenerative Technology, Inc. GlobeNewswire |
| 06-Dec-12 02:30PM | Electronic Equipment Stocks to Consider Buying at Motley Fool |
| 20-Nov-12 04:00AM | Harvard Bioscience Inc. Stock Downgraded (HBIO) at TheStreet |
| 16-Nov-12 01:04PM | HARVARD BIOSCIENCE INC Financials EDGAR Online Financials |
| 08-Nov-12 03:32PM | HARVARD BIOSCIENCE INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 04-Nov-12 09:34AM | New Star Analyst Rankings for Harvard Bioscience, Inc. StarMine |
| 02-Nov-12 09:40AM | New Star Analyst Rankings for Harvard Bioscience, Inc. StarMine |
| 01-Nov-12 03:44PM | HARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online |
| 07:07AM | Q3 2012 Harvard Bioscience, Inc. Earnings Release - Before Market Open CCBN |
| 07:00AM | HBIO Reports Third Quarter 2012 Results GlobeNewswire |
| 26-Oct-12 07:00AM | Harvard Bioscience, Inc. Schedules Third Quarter 2012 Conference Call for November 1, 2012 GlobeNewswire |
| 22-Oct-12 05:33AM | Revisiting The Investment Potential In Electroporation Companies at Seeking Alpha |
| 10-Oct-12 05:00AM | Harvard Bioscience Inc. Stock Upgraded (HBIO) at TheStreet |
| 13-Sep-12 07:00AM | HBIO President David Green to Present at the UBS 2012 Global Life Sciences Conference GlobeNewswire |
| 16-Aug-12 01:04PM | HARVARD BIOSCIENCE INC Financials EDGAR Online Financials |
| 09-Aug-12 11:59AM | HARVARD BIOSCIENCE INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 08-Aug-12 02:44PM | HARVARD BIOSCIENCE INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online |
| 03-Aug-12 12:20PM | HARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online +5.04% |
| 10:58AM | New Star Analyst Rankings for Harvard Bioscience, Inc. StarMine |
| 02-Aug-12 07:07AM | Q2 2012 Harvard Bioscience, Inc. Earnings Release - Before Market Open CCBN |
| 07:00AM | HBIO Reports Second Quarter 2012 Revenue Growth of 5% Over Second Quarter 2011 GlobeNewswire |
| 19-Jul-12 03:42PM | Harvard Bioscience, Inc. Schedules Second Quarter 2012 Conference Call for August 2, 2012 GlobeNewswire |
| 17-Jul-12 09:23AM | Investment Potential In Electroporation Companies at Seeking Alpha |
| 28-Jun-12 10:31AM | Harvard Bioscience: Developments Appear Extraordinary at Seeking Alpha |
| 26-Jun-12 02:56PM | Harvard Bioscience stem cells in Russian tracheal transplants at bizjournals.com |
| 07:00AM | Photo Release -- Harvard Bioscience's "InBreath" Bioreactors Used in World's First Successful Regenerated Laryngotracheal Transplants GlobeNewswire |
| 25-May-12 01:40PM | HARVARD BIOSCIENCE INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online |
| 17-May-12 01:05PM | HARVARD BIOSCIENCE INC Financials EDGAR Online Financials |
| 10-May-12 11:34AM | HARVARD BIOSCIENCE INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 07-May-12 11:26AM | HARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online |
| 05-May-12 09:43AM | New Star Analyst Rankings for Harvard Bioscience, Inc. StarMine |
| 04-May-12 10:18AM | New Star Analyst Rankings for Harvard Bioscience, Inc. StarMine |
| 03-May-12 07:00AM | HBIO Reports First Quarter 2012 Revenue Growth of 8% Over First Quarter 2011 GlobeNewswire |
|
|
| Harvard Bioscience, Inc., together with its subsidiaries, develops, manufactures, distributes, and markets specialized products, primarily apparatus and scientific instruments used to advance life science research and regenerative medicine. It operates through two segments, Life Science Research Tools and Regenerative Medicine Device. The company's products primarily target ADMET testing and molecular biology application areas. Its ADMET testing products include absorption diffusion chambers that measure the absorption of a drug into the bloodstream; well equilibrium dialysis plate for serum protein binding assays; organ testing systems; infusion pumps; behavioral products used in neuroscience, cardiology, psychological, and respiratory studies to evaluate the effects of situational stimuli, drugs, and nutritional infusions on motor and sensory, activity, and learning and test behavior; cell injection systems; ventilators; and electroporation products. The company's molecular biology products include molecular biology spectrophotometers, DNA/RNA/protein calculators, multi-well plate readers, liquid dispensers, and amino acid analysis and gel electrophoresis systems, as well as liquid handling consumables, such as pipettes, pipette tips, autoradiography films, gloves, thermal cycler accessories, and reagents. It also distributes devices, instruments, and consumables used in experiments involving cells, tissues, organs, and animals in the fields of proteomics, physiology, pharmacology, neuroscience, cell biology, molecular biology, and toxicology; and manufactures microdialysis products, synthetic scaffolds, bioreactors, and cell biology and electrophysiology products. The company sells its products to pharmaceutical and biotechnology companies, universities, and government laboratories through distributors, catalogs, and its field sales organization and Website worldwide. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| LEWIS EARL R | Director | Feb 19 | Option Exercise | 3.72 | 27,500 | 102,300 | 97,500 | Feb 25 03:56 PM | | GREEN DAVID | President | Dec 21 | Option Exercise | 3.16 | 14,409 | 45,532 | 1,631,342 | Dec 21 04:44 PM | | GREEN DAVID | President | Dec 21 | Sale | 4.06 | 14,409 | 58,486 | 1,616,933 | Dec 21 04:44 PM | | GREEN DAVID | President | Dec 20 | Option Exercise | 3.16 | 73,591 | 232,548 | 1,690,524 | Dec 21 04:44 PM | | GREEN DAVID | President | Dec 20 | Sale | 4.05 | 73,591 | 298,139 | 1,616,933 | Dec 21 04:44 PM | | GREEN DAVID | President | Dec 19 | Option Exercise | 3.16 | 48,146 | 152,141 | 1,665,079 | Dec 21 04:44 PM | | GREEN DAVID | President | Dec 19 | Sale | 4.04 | 48,146 | 194,414 | 1,616,933 | Dec 21 04:44 PM | | GREEN DAVID | President | Dec 18 | Option Exercise | 3.16 | 45,946 | 145,189 | 1,631,233 | Dec 19 04:46 PM | | GREEN DAVID | President | Dec 18 | Sale | 4.08 | 14,300 | 58,333 | 1,616,933 | Dec 19 04:46 PM | | GREEN DAVID | President | Dec 17 | Option Exercise | 3.16 | 17,908 | 56,589 | 1,603,195 | Dec 19 04:46 PM | | GREEN DAVID | President | Dec 17 | Sale | 4.10 | 17,908 | 73,468 | 1,585,287 | Dec 19 04:46 PM | | GRAZIANO CHANE | Chief Executive Officer | Dec 11 | Option Exercise | 3.48 | 200,000 | 696,000 | 2,645,920 | Dec 13 04:54 PM | | LUSCINSKI SUSAN M | Chief Operating Officer | Dec 11 | Option Exercise | 3.16 | 100,000 | 316,000 | 436,596 | Dec 13 04:53 PM |
|
|
|
|
|
|
